On September 9, 2020 Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, reported that Timothy C. Rodell, M.D., Chief Executive Officer, is scheduled to provide an overview of the Company on Monday, Sept. 14, at 2:00 p.m. EDT (Press release, Aethlon Medical, SEP 9, 2020, https://www.prnewswire.com/news-releases/aethlon-medical-to-present-at-the-hc-wainwright-22nd-annual-global-investment-conference-301124812.html [SID1234564896])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Replays of the presentation will be aired live and available for 90 days. The reply can be accessed at View Source and the investor relations section of Aethlon Medical’s website at www.aethlonmedical.com.